Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Feasibility and Acceptability of PREVAIL (PREserving Valued Activities In Life)

NCT06706999 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.

NCT NCT06706999
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06706999 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Feasibility and Acceptability of PREVAIL (PREserving Valued Activities In Life)
Lead sponsor
University of North Carolina, Chapel Hill
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2025
Completion date
November 16, 2025
Enrollment
63 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, rheumatoid (ra), rheumatoid arthritis (ra)